Physicians from Indiana University report that increasing the dosage of anticancer drugs after the failure of first-line chemotherapy may lead to more succesful outcomes for men with testicular cancer.
The report published in the New England Journal of Medicine states that a considerable number of male patients with germ cell tumor are cured when they are treated with a second round of high dosage chemotherapy after the first round of chemotherapy has failed.
Unusual sensitivity of testicular cells to anticancer medicines is assumed to be behind these successful treatments. This treatment, however, cannot be extended to other types of cancers.
Leave a Reply